Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erritzoe

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Psychopharmacology|November 4, 2021
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyJoanna Kuc, Hannes Kettner, Fernando Rosas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2017
Altered Insula Connectivity under MDMAIshan C Walpola, Timothy Nest, Leor Roseman, et al.
Nuclear Medicine and Biology|July 13, 2004
A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA)Yiyun Huang, Raj Narendran, Sung-A Bae, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 26, 2010
Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levelsAnders Bue Klein, Viktorija Trajkovska, David Erritzoe, et al.
Molecular Psychiatry|April 25, 2025
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Journal of Psychopharmacology (Oxford, England)|April 12, 2024
Psychedelics and the 'inner healer': Myth or mechanism?Joseph Peill, Miriam Marguilho, David Erritzoe, et al.
Neuroimage|September 21, 2010
Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET studyRon Kupers, Vibe G Frokjaer, David Erritzoe, et al.
Elife|March 2, 2021
Self-blinding citizen science to explore psychedelic microdosingBalázs Szigeti, Laura Kartner, Allan Blemings, et al.
EJNMMI Physics|March 10, 2026
Evaluation of the impact of low activity imaging in [<sup>11</sup>C]-(+)-PHNO and [<sup>11</sup>C]UCB-J PET-MR scansDaniela Ribeiro, William Hallett, Oliver Howes, et al.
Psychopharmacology|July 13, 2010
Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjectsKarine Madsen, David Erritzoe, Erik Lykke Mortensen, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Psychopharmacology|November 4, 2021
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyJoanna Kuc, Hannes Kettner, Fernando Rosas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2017
Altered Insula Connectivity under MDMAIshan C Walpola, Timothy Nest, Leor Roseman, et al.
Nuclear Medicine and Biology|July 13, 2004
A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA)Yiyun Huang, Raj Narendran, Sung-A Bae, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 26, 2010
Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levelsAnders Bue Klein, Viktorija Trajkovska, David Erritzoe, et al.
Molecular Psychiatry|April 25, 2025
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesRebecca Harding, Neomi Singer, Matthew B Wall, et al.
Journal of Psychopharmacology (Oxford, England)|April 12, 2024
Psychedelics and the 'inner healer': Myth or mechanism?Joseph Peill, Miriam Marguilho, David Erritzoe, et al.
Neuroimage|September 21, 2010
Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET studyRon Kupers, Vibe G Frokjaer, David Erritzoe, et al.
Elife|March 2, 2021
Self-blinding citizen science to explore psychedelic microdosingBalázs Szigeti, Laura Kartner, Allan Blemings, et al.
EJNMMI Physics|March 10, 2026
Evaluation of the impact of low activity imaging in [<sup>11</sup>C]-(+)-PHNO and [<sup>11</sup>C]UCB-J PET-MR scansDaniela Ribeiro, William Hallett, Oliver Howes, et al.
Psychopharmacology|July 13, 2010
Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjectsKarine Madsen, David Erritzoe, Erik Lykke Mortensen, et al.
Pageof 15